Literature DB >> 9168997

Changes in BRCA2 expression during progression of the cell cycle.

S C Wang1, S H Lin, L K Su, M C Hung.   

Abstract

It has been shown that genetic alterations in BRCA1 and BRCA2 can predispose an individual to develop breast cancer. We investigated the expression of both BRCA2 and BRCA1 during the progression of the cell cycle by northern blot analysis. In MCF-10F (normal breast epithelial cell line) and MCF-7 (breast cancer cell line) cells the expression of BRCA2 RNA was low in G0 and early G1 phases then up-regulated at the G1/S phase junction. Expression of BRCA2 was maintained at relatively high levels when cells progressed through S and G2/M phases. For MCF-7 cells, the level of BRCA2 transcript decreased as cells were released from nocodazole-mediated metaphase arrest. This is consistent with the observation of low but detectable BRCA2 RNA level in G1 phase of the cell cycle. For both cell lines, the patterns of RNA expression of BRCA1 and BRCA2 were similar during the proliferation phase of cell cycle. However, the transcripts from both genes were undetectable in quiescent cells. These results suggest important functions for both BRCA2 and BRCA1 in regulation of cell growth.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9168997     DOI: 10.1006/bbrc.1997.6544

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  BRCA1 and BRCA2 proteins: roles in health and disease.

Authors:  J A Duncan; J R Reeves; T G Cooke
Journal:  Mol Pathol       Date:  1998-10

2.  Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.

Authors:  Y Jin; X L Xu; M C Yang; F Wei; T C Ayi; A M Bowcock; R Baer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

3.  Yeast as a Model to Unravel New BRCA2 Functions in Cell Metabolism.

Authors:  Alessandra Costanza; Nicoletta Guaragnella; Antonella Bobba; Caterina Manzari; Alberto L'Abbate; Claudio Lo Giudice; Ernesto Picardi; Anna Maria D'Erchia; Graziano Pesole; Sergio Giannattasio
Journal:  Front Oncol       Date:  2022-06-06       Impact factor: 5.738

4.  What is known about melatonin, chemotherapy and altered gene expression in breast cancer.

Authors:  Carlos Martínez-Campa; Javier Menéndez-Menéndez; Carolina Alonso-González; Alicia González; Virginia Álvarez-García; Samuel Cos
Journal:  Oncol Lett       Date:  2017-02-10       Impact factor: 2.967

5.  Overexpression of TNKS1BP1 in lung cancers and its involvement in homologous recombination pathway of DNA double-strand breaks.

Authors:  Wei Tan; Hua Guan; Lian-Hong Zou; Yu Wang; Xiao-Dan Liu; Wei-Qing Rang; Ping-Kun Zhou; Hua-Dong Pei; Cai-Gao Zhong
Journal:  Cancer Med       Date:  2017-01-06       Impact factor: 4.452

6.  The role of the redox/miR-6855-3p/PRDX5A axis in reversing SLUG-mediated BRCA2 silencing in breast cancer cells.

Authors:  Marshall Ellison; Mukul Mittal; Minu Chaudhuri; Gautam Chaudhuri; Smita Misra
Journal:  Cell Commun Signal       Date:  2020-01-27       Impact factor: 5.712

7.  DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy.

Authors:  Emil Mladenov; Simon Magin; Aashish Soni; George Iliakis
Journal:  Front Oncol       Date:  2013-05-10       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.